ALPS Medical Breakthroughs ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBIO and other ETFs, options, and stocks.

About SBIO

SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. 

Index-Tracked
Bloomberg US 1000 TR USD
Index-TrackedBloomberg US 1000 TR USD
Category
Health
CategoryHealth
Number of holdings
106
Number of holdings106
Inception Date
Dec 30, 2014
Inception DateDec 30, 2014

SBIO Key Statistics

AUM
82.86M
AUM82.86M
Price-Earnings ratio
-18.25
Price-Earnings ratio-18.25
30-Day yield
-0.46
30-Day yield-0.46
Average volume
25.88K
Average volume25.88K
High today
$44.18
High today$44.18
Low today
$43.10
Low today$43.10
Open price
$43.43
Open price$43.43
Volume
97.64K
Volume97.64K
52 Week high
$45.26
52 Week high$45.26
52 Week low
$22.33
52 Week low$22.33
Expense ratio
0.50
Expense ratio0.50

Stock Snapshot

The current ALPS Medical Breakthroughs ETF(SBIO) stock price is $44.16, with a market capitalization of 82.78M. The stock trades at a price-to-earnings (P/E) ratio of -18.25.

On 2025-11-07, ALPS Medical Breakthroughs ETF(SBIO) stock traded between a low of $43.10 and a high of $44.18. Shares are currently priced at $44.16, which is +2.5% above the low and -0.0% below the high.

ALPS Medical Breakthroughs ETF(SBIO) shares are trading with a volume of 97.64K, against a daily average of 25.88K.

In the last year, ALPS Medical Breakthroughs ETF(SBIO) shares hit a 52-week high of $45.26 and a 52-week low of $22.33.

In the last year, ALPS Medical Breakthroughs ETF(SBIO) shares hit a 52-week high of $45.26 and a 52-week low of $22.33.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.